About

Hyris is an innovation-based, global biotech Company.

Hyris aims to democratize genetic analysis and diagnostic, by offering its partners and clients a disruptive System which enables genetic testing of biological samples in any setting, at any time.
When diagnostic and genetic analysis must be performed under the harshest conditions, Hyris checks all the boxes.

Topics

The Hyris Values

The Hyris Values

RELIABILITY

Hyris is based on a product excellence philosophy, which is the foundation of its customer-centric strategy. Hyris solutions and services are the means to deliver significant benefits to all clients and partners.

INNOVATION

Hyris strives to go over the boundaries of acquired knowledge, constantly exploring new fields of applications and new solutions that incorporate all the elements needed to deploy a top-rating network of biosensing units: anywhere, anytime.

CARE

Hyris always put the user at the center of any solutions, as taking care of life begins with the capability to assess in time the risks to health. Hyris aims to put knowledge, through technology, at the service of life, supporting many different sectors such as healthcare, botanicals, plant health, food control, research activitivies, and more.


A fast-growing, global team of innovators,
with knowledge you can rely on

Hyris People

The Hyris Team

  • Hyris’ resources, management, and partners contribute to the company’s effort to build world-class client-centred solutions via a relevant, global experience in many strategic fields.
  • A growing community of highly-educated employees spread worldwide, covering a wide range of technical roles, currently empowering in the Regulatory, Production and Technical Assistance Departments.
  • A technical team with a diverse and deep background in microsystems R&D, plant biology, medical technology, banking software interfaces and more.
  • 20+ years experience in cooperating with the major players in biomedical systems in developing and transitioning to manufacturing some of the best-known products in the field.
  • Decades of experience in commercializing high-tech products, deployment and implementation of commercial strategies, account management and technical support for clients ranging from small research centres to Fortune-500 global corporations.
  • Hyris consolidated long term partnerships with major actors for legal, financial, accounting and IP protection.
  • Hyris’ investors include professionals with a long and successful track record in financial management, M&A, tech companies.
  • Hyris is constantly engaged with several world-class corporations and partners in the joint development of targeted testing solutions.

A global company
led by knowledge

Milestones

Milestones


  • October 2014

    Hyris Ltd founded in London, UK
  • July 2015

    R&D facilities open in Milan, Italy
  • October 2015

    Hyris obtains EPPO certification for a plant pathology reagent kit
  • January 2016

    bCUBE1.0 completes first successful run
  • April 2016

    First client orders booked, third party integration activities start
  • May 2016

    Key customers demos and technical codevelopment. First commercial revenues booked.
  • October 2016

    Hyris obtains the Seal of Excellence of the European Commission
  • May 2017

    Hyris announces partnership and entry into the Botanicals application area.
  • July 2017

    First platforms and clients in the plant pathology sector
  • August 2017

    bCUBE 2.0 available for sale.
  • March 2018

    Hyris signs strategic partnership agreement for the Botanicals market
  • August 2018

    Hyris launches its platform and product line for Botanicals plant species identification.
  • April 2019

    Hyris launches its product line for Probiotics strains identification.
  • June 2019

    First scientific article in collaboration with the Johns Hopkins University.
  • April 2020

    Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces.
  • September 2020

    Hyris test for the identification of the SARS-CoV-2 in human specimens is approved for sales in Canada as point-of-care test.
  • September 2021

    Hyris presents its new Brand Identity, supporting its fast growth worldwide.

  • October 2014

    Hyris Ltd founded in London, UK
  • July 2015

    R&D facilities open in Milan, Italy
  • October 2015

    Hyris obtains EPPO certification for a plant pathology reagent kit
  • January 2016

    bCUBE1.0 completes first successful run
  • April 2016

    First client orders booked, third party integration activities start
  • May 2016

    Key customers demos and technical codevelopment. First commercial revenues booked.
  • October 2016

    Hyris obtains the Seal of Excellence of the European Commission
  • May 2017

    Hyris announces partnership and entry into the Botanicals application area.
  • July 2017

    First platforms and clients in the plant pathology sector
  • August 2017

    bCUBE 2.0 available for sale.
  • March 2018

    Hyris signs strategic partnership agreement for the Botanicals market
  • August 2018

    Hyris launches its platform and product line for Botanicals plant species identification.
  • April 2019

    Hyris launches its product line for Probiotics strains identification.
  • June 2019

    First scientific article in collaboration with the Johns Hopkins University.
  • April 2020

    Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces.
  • September 2020

    Hyris test for the identification of the SARS-CoV-2 in human specimens is approved for sales in Canada as point-of-care test.

Hyris Research Partners

Newsletter

Subscribe our newsletter for periodical updates about Hyris solutions.

Address


Headquarter

London

Lower Ground Floor
One George Yard
EC3V 9DF - London, UK
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Center

Milan

C.so Garibaldi 60
Milano 20121, Italy
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Asia PAC

Singapore

38 Ang Mo Kio Industrial Park 2
#02-07A - 569511 Singapore
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

US West Coast Sales Inquiries

Los Gatos

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Social